PATENT CLAIM ANALYSIS

Application Number: 15780436
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["544", "405000"]

Abstract:
Provided is a compound (chemotherapeutic agent) effective in the prevention and treatment of hyperlipidemia, obesity, or the like. A phenylimidazole compound or a pharmaceutically acceptable salt thereof represented by the following formula (1):

Claim (Index 7):
The phenylimidazole compound according to  claim 1  or a pharmaceutically acceptable salt thereof, wherein R1 is pyridyl having one or two substituents each independently selected from the group consisting of halogen and halogen-substituted C1-C6 alkyl.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 93.0
- Lexical Diversity: 1.24242
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14022540', '12862418', '12738885', '13133673', '13473230']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8353934099396783
- 35 USC 102 Novelty (BERT): 0.5154559067509674
- Combined Prediction Score: 0.8033996596208073
- Mean Citation Score: 331.818016
- Max Citation Score: 334.57556
- Similarity Product: 272.13966248178

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test